title: Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation.
abstract: Phosphorylation of the transcription factor interferon regulatory factor 3 (IRF3) is essential for the induction of promoters which contain the interferon-stimulated response element (ISRE). IRF3 can be activated by Toll-like receptor 3 (TLR3) in response to the double-stranded RNA mimic poly(I-C) and by TLR4 in response to lipopolysaccharide (LPS). Here we have analyzed the effect of the glucocorticoid dexamethasone on this response. Dexamethasone inhibited the induction of the ISRE-dependent gene RANTES (regulated on activation normal T cell expressed and secreted) in both U373-CD14 cells and human peripheral blood mononuclear cells and also an ISRE luciferase construct, activated by either TLR3 or TLR4. It also inhibited increased phosphorylation of IRF3 in its N terminus in response to LPS and in its C terminus on Ser-396 in response to either poly(I-C) or LPS. Several dexamethasone-induced phosphatases were tested for possible involvement in these effects; MKP1 did not appear to be involved, although MKP2 and MKP5 both partially inhibited induction of the ISRE, pointing to their possible involvement in the effect of dexamethasone. Importantly, we found that dexamethasone could inhibit TBK1 kinase activity and TBK1 phosphorylation on Ser-172, both of which are required for IRF3 phosphorylation downstream of TLR3 and TLR4 stimulation. Our study, therefore, demonstrates that TBK1 is a target for dexamethasone, common to both TLR3 and TLR4 signaling.
authors: School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland. cmccoy@tcd.ie
authors: Claire E
authors: CE
authors: McCoy
authors: Susan
authors: S
authors: Carpenter
authors: Eva M
authors: EM
authors: Pålsson-McDermott
authors: Linden J
authors: LJ
authors: Gearing
authors: Luke A J
authors: LA
authors: O'Neill
mesh_terms: D002478:Cells, Cultured; D018946:Chemokine CCL5 / Q000235:genetics / Q000378:metabolism; D003913:Dextroamphetamine / Q000494:pharmacology; D019281:Dimerization; D004789:Enzyme Activation; D005786:Gene Expression Regulation / Q000187:drug effects; D017930:Genes, Reporter / Q000235:genetics; D005938:Glucocorticoids / Q000494:pharmacology*; D006801:Humans; D050838:Interferon Regulatory Factor-3 / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000494:pharmacology; D010766:Phosphorylation / Q000187:drug effects; D011070:Poly I-C / Q000494:pharmacology; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D051196:Toll-Like Receptor 3 / Q000378:metabolism*; D051197:Toll-Like Receptor 4 / Q000378:metabolism*
chemical_list: D018946:Chemokine CCL5; D005938:Glucocorticoids; D050838:Interferon Regulatory Factor-3; D008070:Lipopolysaccharides; D051196:Toll-Like Receptor 3; D051197:Toll-Like Receptor 4; D017346:Protein Serine-Threonine Kinases; C403191:TBK1 protein, human; D011070:Poly I-C; D003913:Dextroamphetamine